SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| ADOLIN 0.1% W-W CREAM | 0.1 % | Cream · Topical | 1 Bottle | SAR 17.15 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| ADOLIN 0.1% W-W GEL | 0.1 % | Gel · Topical | 1 Bottle | SAR 17.15 | Generic · Prescription | Middle East Pharmaceutical Industries Co Ltd Avalon Pharma | Valid |
| DIFFERIN 0.1% CREAM | 0.1 % | Cream · Topical | 1 Bottle | SAR 18.75 | NCE · Prescription | GALDERMA | Valid |
| DIFFERIN 0.1% GEL | 0.1 % | Gel · Topical | 1 Bottle | SAR 18.75 | NCE · Prescription | GALDERMA | Valid |
| SURECURE 0.1% TOPICAL GEL | 0.1 % | Gel · Topical | 1 Bottle | SAR 18.05 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| WATENE 0.1% CREAM | 0.1 % | Cream · Topical | 1 Bottle | SAR 21.95 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| WATENE 0.1% GEL | 0.1 % | Gel · Topical | 1 Bottle | SAR 21.95 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
| DIFFERIN | 0.1% | gel · topical | GALDERMA LABS LP | Over-the-counter | 31 May 1996 |
| DIFFERIN | 0.1% | cream · topical | GALDERMA LABS LP | Prescription | 26 May 2000 |
| DIFFERIN | 0.3% | gel · topical | GALDERMA LABS LP | Prescription | 19 Jun 2007 |
| ADAPALENE | 0.1% | gel · topical | P AND L | Over-the-counter | 2 Jun 2010 |
| ADAPALENE | 0.1% | cream · topical | FOUGERA PHARMS | Prescription | 30 Jun 2010 |
| ADAPALENE | 0.1% | gel · topical | GLENMARK PHARMS | Over-the-counter | 1 Jul 2010 |
| ADAPALENE | 0.3% | gel · topical | ENCUBE ETHICALS | Prescription | 14 Jun 2012 |
| ADAPALENE | 0.3% | gel · topical | ACTAVIS MID ATLANTIC | Prescription | 27 Oct 2014 |
| ADAPALENE | 0.1% | solution · topical | WAYLIS THERAP | Prescription | 5 Jan 2016 |
| ADAPALENE | 0.3% | gel · topical | SUN PHARMA CANADA | Prescription | 23 Jun 2016 |
| ADAPALENE | 0.1% | solution · topical | WAYLIS THERAP | Prescription | 23 Sep 2016 |
| ADAPALENE | 0.3% | gel · topical | ALEMBIC | Prescription | 18 Jun 2020 |
| ADAPALENE | 0.1% | gel · topical | SUN PHARMA CANADA | Over-the-counter | 14 Jan 2022 |
| ADAPALENE | 0.1% | gel · topical | UNIQUE | Over-the-counter | 30 Jun 2026 |
| DIFFERIN | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution · topical | GALDERMA LABS LP | Discontinued | 31 May 1996 |
| DIFFERIN | 0.1% | lotion · topical | GALDERMA LABS LP | Discontinued | 17 Mar 2010 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
| DIFFERIN | 02148749 | 0.1 % | GEL · TOPICAL | GALDERMA CANADA INC. |
| DIFFERIN | 02231592 | 0.1 % | CREAM · TOPICAL | GALDERMA CANADA INC. |
| DIFFERIN XP | 02274000 | 0.3 % | GEL · TOPICAL | GALDERMA CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
| US NADAC | ADAPALENE 0.1% CREAM | $2.85454 | per GM | 23 Sep 2026 |
| US NADAC | ADAPALENE 0.1% GEL | $0.4655 | per GM | 23 Sep 2026 |
| US NADAC | ADAPALENE 0.1% GEL | $0.33648 | per GM | 23 Sep 2026 |
| US NADAC | ADAPALENE 0.3% GEL | $0.50376 | per GM | 23 Sep 2026 |
| US NADAC | ADAPALENE 0.3% GEL PUMP | $0.85025 | per GM | 23 Sep 2026 |
| US NADAC | GNP ADAPALENE 0.1% GEL | $0.4655 | per GM | 23 Sep 2026 |
| NHS Drug Tariff | Adapalene 0.1% cream | £18.26 | 50 gram | 1 Oct 2026 |
| NHS Drug Tariff | Adapalene 0.1% gel | £18.26 | 50 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 27 Dec 2023 DIFFERIN — safety-related labeling change
Labeling sections changed: Contraindications; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 19 Apr 2023 DIFFERIN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 27 Apr 2022 EPIDUO FORTE — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
All safety entries for adapalene →
Combinations containing Adapalene
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.